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Paradoxical Low-Flow,
Low-Gradient Aortic Stenosis
Adding New Pieces to the Puzzle*
Philippe Pibarot, DVM, PHD,
Jean G. Dumesnil, MD
Québec, Québec, Canada
Low-flow, low-gradient aortic stenosis (AS) is a highly
challenging condition in terms of diagnosis and therapeutic
management. The transvalvular pressure gradient is in-
versely related to the square of aortic valve area (AVA) and
directly related to the square of flow. Hence, a patient with
severe AS may nonetheless present with a low gradient if his
or her left ventricular (LV) output is reduced. This situation
is frequently observed in patients with depressed LV ejec-
tion fraction (LVEF) who often have a low transvalvular
flow and thus a low gradient despite the presence of severe
AS. Conversely, it is generally assumed that patients with
severe AS and preserved LVEF should necessarily have a
high transvalvular gradient. However, recent studies re-
vealed that this perception is erroneous and that a substan-
tial proportion of patients with severe AS may indeed have
a low transvalvular flow and thus a low gradient despite a
preserved LVEF (1–6).
See page 402
In this issue of the Journal, Hermann et al. (7) present a
comprehensive and compelling set of data including Dopp-
ler echocardiography, cardiac catheterization, magnetic res-
onance imaging, blood biomarkers, and myocardial biopsies
in a series of 71 consecutive patients with severe AS having
undergone aortic valve replacement (AVR) compared with a
control group of 17 patients with moderate AS. Impor-
tantly, this study provides novel insights into the pathophys-
iology of low-flow, low-gradient AS and further confirms
that patients with this entity are at a more advanced stage of
their disease. In particular, they elegantly demonstrate that,
compared with patients with classic, normal-flow, high-
gradient AS, these patients have subendocardial myocardial
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relationships to disclose.fibrosis that is at least partially irreversible and that trans-
lates clinically into reduced LV longitudinal shortening
measured using either systolic mitral ring displacement or
tissue Doppler imaging. Such information is precious and
should contribute to improve our understanding of patho-
physiology as well as our diagnostic accuracy.
Clinical Spectrum of Severe AS
The results of Hermann et al. (7) add to other recently
published studies (1–6) to confirm that the clinical spec-
trum of severe AS is more complex than previously believed
and includes, in fact, 3 main entities (Table 1). The
common denominator for these 3 entities is the presence of
a small AVA (1.0 cm2 and/or indexed AVA of 0.6
m2/m2), whereas they may differ markedly in terms of
LVEF and transvalvular flow and gradient, thus complicat-
ing clinical diagnosis and therapeutic management.
Normal-flow, high-gradient AS. LV concentric hypertro-
phy develops in the majority of patients with severe AS in
response to pressure overload. The cavity size is generally
normal or mildly reduced compared with healthy subjects
(Table 1). The increase in wall thickness associated with LV
concentric hypertrophy results in a greater contribution of
wall thickening to endocardial inward displacement (8).
Consequently, LVEF remains in the normal range or may
even be supranormal, which allows maintenance of normal
LV pump function and transvalvular flow rate. These
patients with severe AS and normal flow rate exhibit a high
gradient. Hence, this entity does not present any particular
challenge with regard to grading of AS severity and thera-
peutic management because all Doppler echocardiographic
indexes of stenosis severity (i.e., AVA, 1.0 cm2; mean
radient, 40 mm Hg; peak aortic jet velocity, 4 m/s) are
onsistent with regard to the framework of the guidelines
nd indicate the presence of severe AS.
ow LVEF, low-flow, low-gradient AS. This entity rep-
esents approximately 5% to 10% of the AS population.
hese patients generally have a dilated LV cavity with
arkedly depressed myocardial systolic function, most often
ue to a concomitant cardiomyopathy in relation to isch-
mic heart disease and/or to afterload mismatch (Table 1).
hey have a poor prognosis if treated medically but a high
perative mortality if treated surgically. Low-dose dobut-
mine stress echocardiography is particularly helpful in
hese patients: 1) to assess the presence of myocardial
ontractile reserve; and 2) to differentiate a pseudosevere
rom a true severe stenosis.
reserved LVEF, low-flow, low-gradient AS. We re-
ently reported that a restrictive physiology may develop in
ome patients with severe AS on the basis of the AVA (i.e.,
1.0 cm2 and/or indexed AVA of 0.6 cm2/m2), resulting
in lower transvalvular flow rates (i.e., stroke volume index
35 ml/m2 and/or mean transvalvular flow rate200 ml/s)
nd lower than expected transvalvular gradients (i.e., 40
m Hg) despite the presence of a preserved LVEF (i.e.,
graphy
arterial
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low-flow, low-gradient AS” (1) (Table 1). The results of
Hermann et al. (7) further confirm that this entity may be
present in a substantial proportion of patients, and indeed,
the prevalence that they report for paradoxical low-flow,
low-gradient, severe AS (15%) is consistent with the range
of 14% to 24% observed in previous studies (1–4,6).
Pathophysiology of Preserved LVEF,
Low-Flow, Low-Gradient Severe AS
Additional characteristics previously reported with regard to
this entity include higher prevalence of women, older age,
higher global LV hemodynamic load as reflected by higher
valvuloarterial impedance, higher degree of LV concentric
remodeling, smaller LV end-diastolic volume, and reduced
LV mid-wall myocardial shortening (1–5). Furthermore,
other studies have shown that LV longitudinal shortening is
often decreased in patients with AS and that the extent of
this decrease is directly related to the degree of LV concen-
tric remodeling (8,9). In this regard, the study of Hermann
et al. (7) provides important new information in revealing
that these patients with paradoxical low-flow, low-gradient
AS also have more extensive subendocardial myocardial
fibrosis. Moreover, they show that the extent of tissue
fibrosis is closely correlated with the levels of N-terminal
pro–B-type natriuretic peptide and procollagen type III
N-terminal peptide (r  0.63 and r  0.69, respectively;
both p  0.01) and inversely and closely correlated to the
extent of myocardial longitudinal shortening as measured by
mitral ring displacement (r  0.79, p  0.0001). Inter-
estingly, the latter is also inversely related to the valvuloar-
terial impedance (i.e., the global LV hemodynamic load).
Hence, these observations offer further evidence that,
compared with patients with normal flow and high gradient,
Typical Characteristics of the 3 Main Entities oTable 1 Typical Characteristics of the 3 Ma
Normal-Flow,
High-Gradient
Aortic valve area, cm2 1.0
Indexed aortic valve area, cm2/m2 0.6
Mean gradient, mm Hg 40
Zva, mm Hg·ml
1·m2 4.5
LV end-diastolic diameter, mm 45–55
Relative wall thickness 0.43
LVEF, % 50
Mitral ring displacement, mm 5–15
Global longitudinal strain, % 14–20
Stroke volume index, ml/m2 35
Mean flow rate, ml/s 200
Myocardial fibrosis 
CT valve calcium score, AU 1,650
Plasma NT-proBNP, pg/ml 1,500
AS  aortic stenosis; AU  arbitrary units; CT  computed tomo
NT-proBNP  N-terminal pro–B-type natriuretic peptide; Zva  valvulothose with paradoxical low flow, low gradient are at a moreadvanced stage of their disease, from both structural and
functional standpoints. Indeed, it can be readily surmised
that a greater and more long-standing increase in LV
hemodynamic load results in more pronounced LV concen-
tric remodeling, a smaller LV cavity, more extensive myo-
cardial fibrosis, and thus more severe impairment of LV
filling and intrinsic myocardial function. Furthermore, with
these results, we now have direct evidence that longitudinal
myocardial shortening is affected to a larger extent in these
patients due to more advanced fibrosis in the subendocardial
layer where the myocardial fibers are oriented longitudi-
nally, as hypothesized more than 30 years ago (8). As well,
these abnormalities are largely irreversible after surgery,
which is in accordance with the concept that these patients
are potentially operated on too late in the course of their
disease due to an underestimation of their pathology in
relation to the low gradient.
Clinical Recognition of Low-Flow,
Low-Gradient Severe AS
Clinically, paradoxical low-flow, low-gradient AS is cer-
tainly the most insidious of the 3 clinical entities described
here because the valve stenosis may appear less severe on the
basis of a lower transvalvular gradient (Table 1). Moreover,
LV systolic function may appear normal on the basis of the
preserved LVEF, when, in fact, these patients have a severe
stenosis and a more pronounced impairment of myocardial
structure and function. Because of this particular mode of
presentation, this entity is often misdiagnosed, which may
lead to underestimation of disease severity and inappropriate
delay of AVR. Hence, previous studies report that these
patients have a 40% to 50% lower referral to surgery
compared with those with normal flow (1,2,4), likely due to
underestimation of stenosis severity in light of the relatively
ere Aortic Stenosistities of Severe Aortic Stenosis
Severe AS
rved LVEF (Paradoxical),
w-Flow, Low-Gradient
Reduced LVEF, Low-Flow,
Low-Gradient
1.0 1.0
0.6 0.6
40 40
4.5 4.5
47 50
0.50 0.35–0.55
50 50
8 8
14 14
35 35
200 200
 
1,650 1,650
1,500 1,500
; LV  left ventricular; LVEF  left ventricular ejection fraction;
impedance;   mild;   moderate;   severe.f Sevin En
Prese
Lolow gradient. Indeed, the presence of a high gradient (40
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specificity to identify severe AS. However, because it is
highly flow dependent, the gradient (as well as the peak
velocity) lacks sensitivity and negative predictive value (e.g.,
71% and 46%, respectively, in the study of Hermann et al.
[7]). Hence, 1 important message that these findings
reiterate is that the presence of a low gradient (40 mm
Hg) or velocity (4 m/s) does not exclude the presence of
a severe stenosis in patients with preserved LVEF and that
particular attention should be paid to patients with discor-
dant findings (i.e., with small AVA and low gradient),
especially if they are symptomatic.
As well, the findings of Hermann et al. (7) also further
demonstrate that parameters of LV systolic function based
on endocardial displacement can remain normal despite
significant myocardial damage (5,8,9). In this regard, it is
important to underscore that LVEF is the only index that is
included in the guidelines to identify LV systolic dysfunc-
tion, which is a Class I indication for AVR. Unfortunately,
LVEF markedly underestimates the extent of myocardial
systolic impairment in the presence of LV concentric
hypertrophy such as is often the case in AS patients and
particularly in those with paradoxical low flow (3,5,7–9).
Indeed, the findings of Hermann et al. (7) provide further
argument for the routine use of indexes of myocardial
longitudinal function (e.g., mitral ring displacement, global
longitudinal strain) in addition to LVEF to identify LV
systolic dysfunction and eventually recommend AVR in
patients with severe AS.
In this context, it should be emphasized that the main
pitfall associated with the echocardiographic diagnosis of
paradoxical low-flow and/or low-gradient AS is an error in
the calculation of the stroke volume. Indeed, this measure-
ment is included in the calculation of many parameters
including AVA, systemic arterial compliance, and valvulo-
arterial impedance; moreover, it is derived from 2 separate
measurements (i.e., LV outflow tract diameter and LV
outflow tract time-velocity integral), each having their
potential for error. Hence, a comprehensive Doppler echo-
cardiographic evaluation including independent measure-
ments as well as other diagnostic modalities including valve
calcium scoring by computed tomography and plasma
B-type natriuretic peptide dose have been advocated to
differentiate paradoxical low-flow, low-gradient severe AS
from other situations (i.e., measurement errors, pseudo-
severe AS) (4). Indeed, the findings of Hermann et al. (7)
further contribute to this recommendation by showing that
the indexes of myocardial longitudinal function should also
be valid for this purpose and should thus improve our
diagnostic accuracy. fiFuture Perspectives
Obviously, additional outcome studies are needed to deter-
mine the most appropriate modality and timing of treat-
ment in patients with low-flow, low-gradient AS. However,
in these future studies, it is important to emphasize that it
would not be adequate to include AVR in the endpoints,
given that this endpoint is essentially determined by the
treating physician’s perception of disease severity, which, in
turn, is highly influenced by the magnitude of the gradient
(or peak jet velocity), the latter being often pseudo-
normalized in patients with low-flow states (with preserved
or reduced LVEF). Hence, the most appropriate and robust
endpoints for future studies should be the occurrence of
heart failure and/or cardiovascular mortality, regardless of
the rate of AVR (1,2,4).
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